# Mark A. Watson

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mark-a-watson/

## Facts

| Field | Value |
| --- | --- |
| Citations | 30,215 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 72 |
| i10-index | 132 |
| Last Known Institution | University of Missouri–St. Louis |
| OpenAlex ID | https://openalex.org/A5007830810 |
| ORCID iD | https://orcid.org/0000-0002-3935-9980 |
| Works | 313 |

## Researcher papers

- [Whole-genome analysis informs breast cancer response to aromatase inhibition](https://scholariq.org/papers/whole-genome-analysis-informs-breast-cancer-response-to-aromatase-inhibition/)
- [Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor–Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype—ACOSOG Z1031](https://scholariq.org/papers/randomized-phase-ii-neoadjuvant-comparison-between-letrozole-anastrozole-and/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [RNA modifications and cancer](https://scholariq.org/topics/rna-modifications-and-cancer/)
- [Cancer Cells and Metastasis](https://scholariq.org/topics/cancer-cells-and-metastasis/)

## Researcher university

- [University of Missouri–St. Louis](https://scholariq.org/institutions/university-of-missouri-st-louis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.